References
- Hsueh WA Law RE Cardiovascular risk continuum: implications of insulin resistance and diabetes Am J Med 1998 105 1A 4 14
- Rodriguez-Calvo R Barroso E Serrano L Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A Hepatology 2009 49 1 106 105 19053045
- Nissen SE Nicholls SJ Sipahi I Effect of very high intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 2006 295 13 1556 1565 16533939
- Ridker PM Danielson E Fonseca FA Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 2008 359 21 2195 2197 18997196
- Rajpathak SN Kumbhani DJ Crandall J Barzilai N Alderman M Ridker PM Statin therapy and risk of developing type 2 diabetes: a meta-analysis Diabetes Care 2009 32 10 1924 1929 19794004
- Vlachopoulos C Ioakeimidis N Aznaouridis K Lazaros G Tousoulis D Statins in diabetes mellitus Curr Pharm Des Epub 2017 8 15
- Shetty GK Conomides PA Horton ES Mantzoros CS Veves A Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 2004 27 10 2450 2457 15451915
- Blom WA Stafleu A de Graaf C Kok FJ Schaafsma G Hendriks HF Ghrelin response to carbohydrate-enriched breakfast is related to insulin Am J Clin Nutr 2005 81 2 367 375 15699223
- Gruzdeva O Uchasova E Belik E Dyleva Y Shurygina E Barbarash O Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance BMC Cardiovasc Disord 2014 14 7 24433403
- Killip T3rd Kimball JT Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients Am J Cardiol 1967 20 4 457 464 6059183
- Katz A Nambi SS Mather K Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 2000 85 7 2402 2410 10902785
- Mitsuhashi T Hibi K Kosuge M Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes JACC Cardiovasc Imaging 2011 4 4 392 401 21492815
- Jukema JW van der Hoorn JW Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy Expert Opin Pharmacother 2004 5 2 459 468 14996641
- Teraoka N Mutoh M Takasu S Inhibition of intestinal polyp formation by pitavastatin, a HMG-CoA reductase inhibitor Cancer Prev Res (Phila) 2011 4 3 445 453 21233289
- Barylski M Nikolic D Banach M Toth PP Montalto G Rizzo M Statins and new-onset diabetes Curr Pharm Des 2014 20 22 3657 3664 24040871
- Sehra D Sehra S Sehra ST Cardiovascular pleiotropic effects of statins and new onset diabetes: is there a common link: do we need to evaluate the role of KATP channels? Expert Opin Drug Saf 2017 16 7 823 831 28571494
- Sattar N Preiss D Murray HM Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 2010 375 9716 735 742 20167359
- Zaharan NL Williams D Bennett K Statins and risk of treated incident diabetes in a primary care population Br J Clin Pharmacol 2013 75 4 1118 1124 22845189
- Sampson UK Linton MF Fazio S Are statins diabetogenic? Curr Opin Cardiol 2011 26 4 342 347 21499090
- Polonsky KS Gumbiner B Ostrega D Griver K Tager H Henry RR Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM Diabetes 1994 43 7 871 877 8013750
- Miyagishima K Hiramitsu S Kato S Efficacy of atorvastatin therapy in ischaemic heart disease – effects on oxidized low-density lipoprotein and adiponectin J Int Med Res 2007 35 4 534 539 17697531
- Kadoglou NP Sailer N Kapelouzou A Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes Acta Diabetol 2012 49 4 269 276 21748474